Angiex Secures $31M For Phase 1 Dose Escalation Of ADC AGX101
17 Nov 2025 //
GLOBENEWSWIRE
Abzena Supplies Clinical Trial Material For Angiex`s AGX101 Study
08 Aug 2024 //
PR NEWSWIRE
Angiex Doses First Patient In Phase 1 Trial Of AGX101 For Solid Tumors
07 Aug 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support